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Executive dysfunction is frequently reported in Alzheimer’s disease (AD) and the frontal variant 
of frontotemporal dementia (FTD). More specifically, inhibitory dysfunction is observed early in 
AD and inhibitory deficits are also prominent in patients with FTD. However, few studies have 
simultaneously explored and compared inhibitory abilities in both degenerative diseases. 
Consequently, the aim of this study was to compare verbal and motor inhibitory processes in the 
initial stages of AD and the frontal variant of FTD. Stroop and go/no-go tasks were administered. 
The results demonstrate that, on the go/nogo task, AD and FTD patients do not produce more 
errors than control subjects. However, both groups are impaired on the Stroop task (mainly with 
regard to the error score) but do not differ from each other. These results indicate that AD and 
FTD patients do not present a general impairment of their inhibitory abilities. Moreover, these 
two kinds of dementia present similar quantitative and qualitative inhibitory impairments on the 
two tasks, although their patterns of structural and functional cerebral impairments are known to 
be different. The presence of similar inhibitory deficits despite very different patterns of brain 
damage is in agreement with the hypothesis that inhibitory dysfunction in the two groups of 
patients depends on a disconnection process between anterior and posterior cerebral areas, rather 
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Executive dysfunction is frequently reported in neurodegenerative diseases such as Alzheimer’s 
disease (AD; for a review, see Collette & Van der Linden, 2004) or frontotemporal dementia 
(FTD; for a review, see Grossman, 2002). Inhibitory control is classically considered as 
representing an important executive function (e.g., Miyake et al., 2000). Inhibitory impairments 
have been reported in several neuropsychological conditions, as well as in normal aging (e.g., 
Hasher & Zacks, 1988) and numerous psychopathological syndromes (for a review, see Nigg, 
2000). Inhibition is generally defined as the set of processes that allow the suppression of  
previously activated cognitive contents, the clearing of irrelevant actions or of attentional focus 
from consciousness, and the resistance to interference from potentially attention-capturing stimuli 
(Bjorklund & Harnishfeger, 1995). Consequently, different aspects of inhibitory control may be 
distinguished, including preventing access to goal-irrelevant information that may be partially 
activated, restricting access to strong but situationally inappropriate responses, and suppressing 
the activation of no-longer-relevant information. Inhibitory processes have been examined in 
pathological populations by using different procedures, the most frequently used being the Stroop 
task (Stroop, 1935), the negative priming procedure (Neill, 1977; Tipper, 1985), the inhibition of 
return paradigm (Posner & Cohen, 1984), the go/no-go task (Band & Van Boxtel, 1999) and the 
Hayling task (Burgess & Shallice, 1996). 
Inhibitory deficits have frequently been reported in the first stages of Alzheimer’s disease 
(for reviews, see Amieva et al., 2004; Balota & Faust, 2001; Collette & Van der Linden, 2002b). 
Typically, the Stroop interference effect is considerably greater in AD patients than in healthy 
elderly controls, even after adjustment of interference scores for processing speed (Amieva et al., 
2004; Bondi et al., 2002; Fisher et al., 1990; Koss et al., 1984; Spieler et al., 1996). Similarly, a 
less reliable or absent negative priming effect has been observed in these patients (Amieva et al., 
2002; Sullivan et al., 1995; see, however, Langley et al., 1998) and weaker semantic inhibition 
abilities have also been observed (Collette et al., 1999; Duchek et al., 1998). Nevertheless, not all 
inhibitory processes appear to be impaired in AD. Little evidence of inhibitory dysfunction has 
been found in tasks that assess motor response inhibition (Amieva et al., 2002; see, however, 
Collette et al., 2002c) and inhibition-of-return (Danckert et al., 1998; Faust & Balota, 1997; 
Langley et al., 2001). 
It is noteworthy that very few studies have attempted to determine how general the 
inhibitory dysfunction in AD is by administering a battery of inhibitory tasks to a single group of 
patients. In a first study, Collette et al. (1999) administered a series of 6 executive tasks to a 
group of AD patients, and demonstrated that the impaired performance on all these tasks can be 
grouped into two factors, representing respectively dual task coordination and inhibitory 
processes. More recently, Belleville et al. (2006) administered two tasks assessing verbal 
inhibitory processes, the Stroop and the Hayling tasks,  to a group of AD patients and elderly 
subjects, and demonstrated impaired performance on both tasks in the patients. Such results are 
consistent with the view of a generality of inhibitory dysfunction in AD, at least in the verbal 
domain. However, if the majority of the patients was impaired on the Hayling task, only 50% 
showed deficits on the Stroop task that cannot taken into account, at least in part, by reading or 
naming difficulties. The existence of a general impairment across domains was reported by 
Collette et al. (2002c) who did not find evidence of preserved inhibitory functioning in a group of 
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AD patients by using the Stroop, Hayling and go/no-go tasks.  However, Amieva et al. (2002) 
obtained data in agreement with the hypothesis of some specificity in the inhibitory dysfunction 
in AD. Indeed, these authors observed impaired performance on the negative priming and Stroop 
tasks, but not on the go/no-go task, and only limited impairment was observed on the stop-signal 
task, suggesting that motor response inhibition may be relatively spared in those patients. 
Discrepant results on the go/no-go task, in particular, could be attributed to the severity of the 
disease since the group of AD patients in the Collette et al. study had a lower score and more 
variable performance on the MMSE than the patients in the Amieva et al. study. Finally, intact 
performance on tasks of interference resolution and directed forgetting in working memory  was 
recently found to be associated with impaired performance on two semantic inhibitory tasks (the 
Hayling and flanker tasks) (Collette et al., submitted). These results also  favored specificity 
rather than generality of inhibitory dysfunction in AD patients. 
Behavioural disorders constitute a major clinical characteristic of FTD patients (Gregory 
& Hodges, 1996; Gregory et al., 1998). Indeed, these patients present a number of behavioural 
disturbances such as inflexibility, disinhibition and impulsivity, distractibility and lack of 
persistence, as well as perseverative behaviour (Gustafson, 1987, 1993), and these behavioural 
abnormalities are associated with cognitive deficits involving executive functioning in particular. 
Indeed, studies of cognitive functioning in the frontal variant of FTD have found a significant 
impairment on executive tasks, associated with variable memory performance, but only moderate 
deficits affecting language, constructional abilities and IQ (Jagust et al., 1989; Johansen & 
Hagberg, 1989; Miller et al., 1991; Neary et al., 1986; Pachana et al., 
1996). However, at this time very few studies have been interested in formally exploring 
inhibitory dysfunction in these patients. Using a Stroop task, Perry et al. (2000) compared the 
performance of AD patients to that of patients with the frontal and temporal variants of FTD. 
Their results indicated poorer performance for all three groups of patients in comparison to 
control subjects, but no significant differences among the dementia groups. Similarly, Pachana et 
al. (1996) demonstrated that control subjects performed at a significantly higher level than both 
AD and FTD patients on the time measure of the Stroop task, but no significant difference was 
detected between patient groups. Mendez et al. (2005), using an alternate tapping task and the 
go/no-go task, reported significant differences between FTD patients who did and did not show 
sociopathic behaviour. Semantic inhibition deficits have also been shown in these patients using 
the Hayling task (Lough et al., 2006). Finally, Dimitrov et al. (2003) compared the inhibitory 
performance of FTD patients to that of matched control subjects using the  stopsignal and 
negative priming tasks. The results indicated a moderate impairment, in the sense that, on the 
stop-signal task, the FTD patients were less accurate in their ‘go’ responses and marginally less 
able to inhibit their responses on the ‘stop’ trials. In the negative priming task, FTD patients, 
unlike control subjects, did not show the negative priming effect. However, this result must be 
interpreted with caution since no interaction between group and task condition was found. 
Moreover, directly comparing the patients’ performance on the two inhibitory tasks was difficult 
since the two tasks were not performed by exactly the same patients, and no indication was 
provided of why some patients withdrew or whether the testing occurred at the same time for the 
two tasks. 
Overall, the results of these studies indicate that inhibitory dysfunction is frequently found 
in AD and FTD patients. However, at this time, no study has formally compared the inhibitory 
capacities of these patients using tasks that assess various inhibitory processes. Consequently, the 
aim of the present study was to give AD patients, patients with the frontal variant of FTD and 
matched control subjects two tasks assessing inhibitory processes that are considered to be 
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separate in the literature (for example, Harnishfeger, 1995; Nigg, 2000): the Stroop task, which 
involves the inhibition of compelling verbal responses, and the go/no-go task, which involves the 
inhibition of compelling motor responses. These tasks were selected because they measure the 
ability to inhibit a dominant response but involve two different (verbal and motor) response 
modalities. Moreover, functional neuroimaging studies in healthy subjects demonstrated that the 
Stroop and the Go-No tasks were not associated to similar cerebral network (Collette & Van der 
Linden, 2002a). In a previous study, Amieva et al. (2002) demonstrated an impaired performance 
on the Stroop task only in AD patients. We were interested to replicate these last results in AD, 
and to determine whether they could be extended to FTD. 
Comparison of the performance of each patient group to that of healthy control subjects 
will make it possible to determine the generality or specificity of inhibitory dysfunction in each 
pathology. Moreover, a comparison of the two groups of patients will allow us to determine 
whether the pattern of deficit is similar, at both quantitative and qualitative levels. This is a key 
question, since these two neurodegenerative diseases are associated with specific patterns of 
cerebral hypometabolism in functional imaging studies (Frisoni et al., 1996; Salmon et al., 1994, 






Sixty-six community-dwelling adults volunteered to participate in this study. All subjects had 
normal or corrected vision and normal or corrected hearing. The 28 normal elderly subjects (13 
men and 15 women) had an average age of 70.6 ± 6.8 years (range = 53–82). These subjects were 
alert, and had no history of neurological problems, alcohol abuse or psychiatric disorders. All 
elderly participants were native speakers of French and did not report any medical, neurological 
or sensory defects, or use of medication likely to alter cognitive functioning. 
A total of 38 patients attending the Day Care Centre for Memory Disorders in the Elderly 
(University Hospital of Liège) also participated in this study. Clinical diagnoses were made 
according to consensual criteria for probable AD (McKhann et al., 1984) and FTD (Neary et al., 
1998) based on (1) the demographic information and clinical history obtained during an interview 
with the patient and a caregiver, and (2) neurological and general examinations. To perform the 
diagnosis, the neurologists  had access to recent anatomical neuroimaging and laboratory data, as 
well as a complete assessment of cognitive functioning performed by a neuropsychologist. 
Twenty-five patients (8 men and 17 women) met the NINCDS-ADRDA criteria for probable 
Alzheimer’s disease (MacKhann et al., 1984). All patients had suffered from progressive 
worsening of memory problems for at least 6 months. Structural neuroimaging showed only 
slight atrophy or mild leukoaraiosis. The patients’ ages ranged from 55 to 79 years (mean age: 
72.5 ± 5.8 years). Thirteen patients (5 men and 8 women) were selected according to recent 
consensual diagnostic criteria for frontotemporal dementia (Neary et al., 1998). The FTD patients 
showed the behavioural presentation of the disease (the frontal variant or fvFTD); cases with 
specific characteristics of semantic dementia and primary progressive aphasia were excluded 
from this study. These patients’ ages ranged from 54 to 76 years (mean age: 65.7 ± 7.5 years). 
Neither AD nor FTD patients suffered from any other medical or neurological condition and they 
did not take medication that would significantly affect their cognitive performance. They were 
able to hear and see adequately and follow instructions. 
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The normal elderly participants and the two groups of patients were given the Mattis 
Dementia Rating Scale (Mattis, 1973), which is widely used to screen for global cognitive 
impairments. All control subjects had a total score of more than 130 on this scale (mean: 139.1 ± 
3.3), which constitutes a cut-off score to discriminate normal aging from dementia (Monsch et 
al., 1995). The control subjects did not differ from AD and FTD patients according to age 
[respectively, U = 277.5; Z = 1.29, p > .1; and U = 125.5; Z =  –1.59, p > .1] and education level 
[respectively, U = 284, Z = –1.18, p > .1; and U = 166.5, Z = 0.47, p >.1]. Overall performance 
on the Mattis Dementia Rating Scale was significantly lower for AD patients (121 ± 9.16) than 
for control subjects [U = 7.5; Z = –6.11, p < .0001] and also for FTD patients (127.3 ±9.1) than 
for control subjects [U = 20; Z = –4.55; p < .0001]. Finally, AD and FTD patients differed 
regarding age [U = 75.5, Z = –2.68; p < .01] but not education level [U = 120, Z = 1.42; p > .1] or 
performance on the Mattis Dementia Rating Scale [U = 99, Z = 1.96, p > .05]. 
The study was approved by the Ethic Committee of the University Hospital in Liège and 
informed consent was obtained in all patients and control subjects. 
 
Procedure 
The participants were tested individually during a two-hour session in a quiet room. Before each 
task, the subject was given instructions, and a pre-test was performed to ensure that the 
instructions were understood. Both inhibitory tasks were presented on a microcomputer equipped 
with a touch screen. Two PVC hand rests, each containing two lateral photoelectric cells, were 
connected to the computer and placed in front of it. During the test session, subjects were asked 
to keep their hands on the PVC hand rests at all times before giving their motor response and to 
put them back on the hand rests after doing so. This equipment made it possible to separately 
collect in the go/no-go task the subjects’ latency in lifting their hands from the start position after 
the stimulus onset and the time spent reaching the target on the screen. Naming latencies on the 





The subjects were presented with colour names (BLUE, RED, YELLOW, GREEN) printed in a 
contrasting ink colour (e.g., BLUE printed in red). In the interference task, the instruction was to 
name the ink colour and to ignore the meaning of the word. The task comprised 48 trials. After 
each response by the subject, the experimenter pressed one of three keys to code the response as 
correct, incorrect or invalid. The code response given by the experimenter initiated the next trial. 
Each participant began with a practice block of 12 trials. A control task was also administered 
consisting of 48 trials in which a colour patch, either red, yellow, green or blue, appeared in the 
centre of the screen. The subject was told to name the colour of the patch presented. 
 
Go/no-go task 
First, subjects were asked to perform a simple reaction time task in which they had to touch, as 
rapidly as possible, a red circle appearing in the centre of the screen for 20 trials. The go/no-go 
task was then performed. The task comprised 20 trials in which subjects were presented with 
either the red circle or a blue triangle in a pseudo-random order. Subjects were told to respond to 
the red circle by touching it on the screen as quickly as possible, and not to respond to the blue 
triangle at all. Fifty percent of the trials were ‘Go’ trials and the other 50% were ‘No-go’ trials. In 
the ‘No-go’ trials in which the distracter stimulus appeared, two different types of errors were 
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possible: subjects could wrongly remove their hand from the starting point, constituting the first 
error type; then they could replace their hand or continue the action by touching the distracter 
stimulus on the screen, constituting the second error type. 
 
Statistical analyses 
As most of the data were not normally distributed, the nonparametric Wilcoxon test was used 
throughout to analyse intergroup and within-group differences. Thus, the statistical tests were 
done on the mean rank of scores and the mean rank of times of subjects. However, the mean 
scores and the mean times are also reported as an indicator of data trends. The nonparametric 
Spearman test was used to do correlation analyses. Statistical analyses were done using 
STATISTICA software (StatSoft France, 2001). To take into account the age difference between 
AD and FTD patients, ANCOVA were also performed with age as a confounding variable. Since 






Subjects’ mean latencies to name the ink colour of the stimuli and mean number of errors of are 
shown in Table 1. Only reaction times for correct trials were analysed. 
 
 
Table 1. Performance of normal elderly subjects, AD patients and FTD patients on the Stroop 
test. 
 Normal controls 
(n = 28) 
M (SD)
AD patients 
(n = 25) 
M (SD)
FTD patients 
(n = 13) 
M(SD) 
Colour naming task 
Naming latency (ms)  719 (150) 934 (305) 933 (181) 
Errors  0.14 (0.36) 0.60 (1.19) 0.50 (0.90) 
Stroop task 
Naming latency (ms)  985 (184) 1425 (524) 1424 (281) 
Errors  0.96 (1.14) 4.88 (6.37) 3.77 (3.22) 
Interference ratio1  1.38 (0.16) 1.54 (0.35) 1.57 (0.44) 
Interference ‘differential score’2   266 (110) 491 (318) 491 (384) 
1 Naming latency on Stroop ÷ naming latency on colour naming 
2 Naming latency on Stroop – naming latency on colour naming 
 
 
The comparison of the performance of AD patients and normal elderly subjects on the 
colour naming task demonstrated significantly increased naming latency for AD patients [U = 
188, Z = 2.29; p < .005] but a similar error rate in the two groups [U = 282, Z = 1.66, p > .9]. On 
the Stroop task, both the naming latencies and error rates were significantly higher for AD 
patients than for normal elderly subjects [respectively, U = 159, Z = 3.40, p < .001; and U = 150, 
Z = 3.55, p < .001]. The interference ratio (naming latency on the Stroop task ÷ naming latency 
on the colour naming task) was marginally different for the groups [U = 247, Z = 1.83, p < .066]. 
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Their performance, however, became significantly different when a subtraction score 
(interference – naming) was used [U = 206, Z = 2.57, p < .05].  
The comparison of the performance of FTD patients and normal elderly subjects on the 
colour naming task demonstrated a significant difference between the groups for naming latency 
[U = 53, Z = 3.39, p < .001] but not for error rates [U = 134, Z = 1.44, p < .1]. On the Stroop task, 
both the naming latencies and the error rates were significantly higher for FTD patients than for 
elderly subjects [respectively, U = 27, Z = 4.16, p < .001; and U = 78, Z = 2.91, p < .005]. The 
interference ratio (naming latency on the Stroop task ÷ naming latency on the colour naming 
task) was not statistically different for the groups [U = 146, Z = 0.13, p > .5]. Again, this 
difference became significant when assessed with a subtraction score (interference – naming) [U 
= 81, Z = 2.57, p < .05]. 
Finally, the comparison of the performance of AD and FTD patients failed to find any 
significant differences for the colour naming task [naming latency: U = 137, Z = 0.42, p > .5; 
naming errors: U = 150, Z = 0, p > .5]. Similarly, no significant differences were found on the 
Stroop task [naming latency: U = 133, Z = 0.55, p > .5; naming errors: U = 157, Z = 0, p > .5]. 
Finally, the interference ratio (naming latency on the Stroop task ÷ naming latency on the colour 
naming task) was also similar between groups [U = 147, Z = 0.62, p > .5], as was the subtraction 
ratio (interference – naming) [U = 145, Z = –0.16, p > .5]. 
 
Go/no-go task 
Simple reaction time condition 
The mean simple reaction times and error rates of the normal controls and the two groups of 
patients are shown in Table 2. Comparison of the performance of AD patients and normal elderly 
subjects revealed significantly longer response latencies and reaching times in AD patients 
[respectively, U = 176, Z = 3.10, p < .005; and U = 75, Z = 4.90, p < .0001]. Similar analyses 
were performed with the group of FTD patients and again found significantly longer response 
latencies and reaching times [respectively, U = 73, Z = 3.05, p < .005; and U = 62, Z = 3.05, p < 
.001]. However, the comparison of AD and FTD patients demonstrated no significant differences 
for these measures [response latencies: U = 149, Z = 0.41, p > .5; reaching times: U = 112, Z = –
1.55, p > .5]. 
Go/no-go condition 
The subjects’ mean reaction times and error rates on the go/no-go task are also shown in Table 2. 
Only analyses for “leaving hand” errors were reported since no control subject or patient 
produced a touching error. Both responses latencies and reaching times were significantly longer 
for AD patients than for elderly subjects [respectively, U = 174, Z = 3.14, p < .005; and U = 80, Z 
= 4.18, p < .0001]. Time ratios were calculated between the simple reaction time task and the 
go/no-go task in order to assess the cognitive slowing during ‘go’ trials attributable to the 
presence of ‘no-go’ trials, and to reduce the influence of patients’ cognitive slowing on group 
differences. As can be seen, these mean ratios were not significantly different for the groups, 
either for the response latencies or for the reaching times 
 [respectively, U = 287, Z = 1.12, p > .1; and U = 349, Z = –0.01, p > .5]. Similarly, no 
significant difference appeared when a subtraction score (go/no-go – simple reaction time) was 
used [respectively, U = 343, Z = 0.12, p > .5; and U = 343, Z = 0.12, p > .5]. In the ‘no-go’ trials, 
errors consisting in removing the hand from the starting point after the appearance of the 
distracter stimulus on the screen were not significantly different between the AD patients and the 
elderly controls [U = 327, Z = 0.42, p > .5]. 
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The comparison of FTD patients and normal elderly subjects also demonstrated 
significantly longer response latencies and reaching times for FTD patients [respectively, U = 58, 
Z = 3.47, p < .001; and U = 67, Z = 3.22, p < .05]. However, these differences disappeared when 
time ratios were used [response latencies: U = 127, Z = 1.54, p > .1; reaching times: U = 181, Z = 
0.03, p > .5]. Similarly, no significant difference appeared when a subtraction score (go/no-go – 
simple reaction time) was used [respectively, U = 174, Z = 0.22, p > .5; U = 174, Z = –0.22, p > 
.5]. The number of errors in the ‘No-go’ trials was also similar for the two groups [U = 160, Z = 
0.62, p > .5]. 
Finally, the comparison of the two groups of patients demonstrated similar performance in 
terms of both response latencies [U = 132, Z = 0.93, p > .1] and reaching times [U = 113, Z = –
1.52, p > .1], as well as for time ratios [response latencies: U = 153, Z = 0.29, p > .5; reaching 
times: U = 159, Z = –0.11, p > .5], difference between simple reaction time and go/no-go 
[response latencies: U = 159, Z = –0.11, p > .5; reaching times: U = 154, Z = –0.26, p > .5] and 
errors in the ‘no-go’ trials [U = 155, Z = 0.22, p > .5]. 
 
 
Table 2. Mean reaction times of normal elderly subjects, AD patients and FTD patients on the 
simple reaction time and the go/no-go tasks. 
 Normal controls 
(n = 28) 
M (SD)
AD patients 
(n = 25) 
M (SD)
FTD patients 
(n = 13) 
M(SD) 
Simple reaction time (without any ‘no-go’ trial) 
Mean response latency (ms)  356 (96) 505 (245) 527 (161) 
Mean reaching time (ms)  514 (115) 842 (266) 726 (227) 
Go/no-go task 
Response latency (ms)1  468 (85) 602 (177) 636 (182) 
Reaching time (ms)1  513 (106) 805 (266) 722 (236) 
Hand movement errors  2.21 (1.29) 2.56 (1,85) 2.85 (2.34) 
Touching errors  0 0 0 
Time ratios 
Response latency ratio1  0.76 (0.12) 0.83 (0.25) 0.84 (0.17) 
Reaching time ratio1  1.01 (0.19) 1.21 (1.04) 1.01 (0.15) 
Response latency difference2  –112 (66) –96 (160) –109 (124) 
Reaching time difference2  1.4 (102) 37 (278) 4 (118) 
1 Simple reaction time task ÷ go/No-go task 




Correlation analyses were performed separately for the two patient groups between the two 
interference ratios on the Stroop task and the two ratios for response latencies on the go/no-go 
task. These measures were also correlated to the overall level of dementia as assessed by the 
Mattis DRS. The only significant correlation was found between the subtraction time ratio scores 
on the Stroop and go/no-go tasks in the FTD patients [r(12) = 0.68, p < .05]. 
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The main goal of this study was to determine the generality of inhibitory dysfunction in two 
neurodegenerative conditions, AD and FTD, by using tasks assessing motor and verbal inhibitory 
processes. Moreover, we were interested in directly comparing the patterns of performance 
presented by these patients at a mild stage of the disease. 
The results obtained can be summarised as follows. On the Stroop task, both AD and FTD 
patients demonstrate a slowing down (as evidenced by response latencies) in the naming and 
interference conditions. Moreover, specific inhibitory difficulties affecting this task are observed 
in both populations. Indeed, in comparison to normal elderly subjects, AD and FTD patients 
produced more errors in the interference condition and a higher interference ratio (as assessed by 
a subtraction score). However, these inhibitory difficulties are similar in both groups of patients. 
With regard to the go/no-go test, the simple reaction time condition resulted in longer response 
latencies and reaching times in the two groups of patients in comparison with normal elderly 
subjects, but no differences between the two groups of patients. In the go/no-go condition, longer 
response latencies and reaching times were observed in the two groups of patients compared to 
normal elderly subjects, but these differences disappeared when a ratio score was considered. No 
differences between patients and control subjects were observed for the errors on the ‘no-go’ 
trials. Finally, as was previously observed for the Stroop task, no significant differences between 
AD and FTD patients were observed on these measures (Pachana et al., 1996; Perry et al., 2000). 
Previous studies that explored inhibitory functioning in FTD and AD patients also found 
consistent impairment on the Stroop task (e.g., Amieva et al., 2004; Pachana et al., 1996; Perry et 
al., 2000; Spieler et al., 1996), and, as observed in the present study, that impairment was similar 
in scope in both groups of patients (Pachana et al., 1996; Perry et al., 2000). With regard to motor 
inhibition, results of previous studies are less consistent, with different studies indicating 
impaired (Collette et al., 2002c) or normal (Amieva et al., 2002) performance in AD, whereas 
impaired performance was also reported in FTD (Dimitrov et al., 2003). However, most of these 
studies did not control for the influence of a general slowing down on inhibitory performance. On 
the other hand, we determined inhibitory functioning with ratio scores that take these aspects of 
processing speed into account, which suggests that the inhibitory dysfunction observed in these 
populations cannot be related to an impairment of a general speed factor, as has sometimes been 
proposed for normal aging (Verhaegen & De Meersman, 1998). 
Taken as a whole, the results obtained in this study indicate that neither AD nor FTD 
patients present a widespread inhibitory dysfunction. Indeed, although both groups of patients are 
impaired on the Stroop task (both for response times and, most obviously, for error scores), they 
do not make more errors on the ‘no-go’ trials of the go/no-go condition. Moreover, only one 
significant correlation was observed between inhibitory measures on the two tasks. The result of 
poor correlations between tasks supposed to reflect a same inhibitory (or more generally 
executive) process was already reported in the literature (see for example, Shilling et al., 2002). If 
these results can be interpreted as reflecting a weak validity of the construct of inhibition (Rabbit 
et al., 2001), we can also consider that it constitutes a supplementary argument to consider that 
the Stroop and Go/No-go tasks really tap two distinct inhibitory processes, that are differentially 
affected in AD and FTD. This pattern of results is in agreement with the theoretical proposals of 
a growing number of authors who consider that inhibitory functioning actually refers to a series 
of independent processes (e.g., Bjorklund & Harnishfeger, 1995; Dempster & Corkill, 1999a, b 
Pulished in : Cortex (2007), 43, 866-874 
Status : Postprint (Author’s version)  
 10
Nigg, 2000). In that context, Houghton and Tipper’s (1994) proposal appears particularly 
interesting. These authors considered the cognitive operations on which inhibitory mechanisms 
are exerted and stated that ‘the strength of the inhibition continually adapts to the strength of the 
to-be-ignored inputs’ (p. 107). In other words, the strength of the cognitive operation/content that 
has to be suppressed will determine the degree of effortfulness of the mechanisms required to 
inhibit it. This characteristic of inhibitory functioning may be relevant in explaining why 
performance on the go/no-go task is preserved in AD and FTD. Indeed, in our study, 50% of 
trials were ‘go’ trials and 50% were ‘no-go’ trials (this is a classical proportion for this kind of 
task, cf. Zimmerman, 1994). This would have resulted in relatively weak reinforcement of the 
motor response to ‘go’ trials. On the other hand, most of the tasks impaired in AD patients share 
the characteristic that the process to be suppressed is salient or mandatory, as in the Stroop test, 
which calls for the inhibition of the reading of familiar names, known to be an over-learned 
mandatory process, or the Hayling task, which requires the suppression of a mandatory word that 
springs to mind. In that case, the inhibitory processing required is necessarily effortful and 
controlled, which explains the difficulties AD and FTD patients have in performing this kind of 
task. 
It must be emphasised that FTD and AD patients present similarly impaired performance 
on the Stroop task (for both response times and accuracy of responses). Very few studies have 
compared the inhibitory abilities of AD and FTD patients, but those that did also demonstrated a 
similar impairment in the two groups of patients (Pachana et al., 1996; Perry et al., 2000). These 
data appear rather surprising since each pathology is associated with specific morphological and 
metabolic impairments. Indeed, functional neuroimaging studies indicate that patients with FTD 
present hypometabolism or hypoperfusion predominantly in the medial frontal area as well as in 
the temporal pole, while AD is associated with decreased cerebral blood flow or hypometabolism 
preferentially observed in the parieto-temporo-occipital associative cortex (Frisoni et al., 1996; 
Salmon et al., 1994, 2003; Sjogren et al., 2000). In that context, two explanations can be 
tentatively proposed to explain the similar impairments of our two groups of patients. First, it 
could be argued that performance on the Stroop task is impaired in the same way in our two 
populations for different cognitive reasons. However, both similar inhibitory performance (for 
both response times and accuracy of responses) and similar processing speed were observed in 
our two groups. Moreover, processing speed did not influence inhibitory dysfunction in either 
group. Taken as a whole, 
 these findings do not support the hypothesis that different cognitive processes may explain the 
similar deficit observed in the AD and FTD patients. 
From a neuroimaging viewpoint, an alternative hypothesis would be that impairment on 
the Stroop task in AD and FTD is not due to hypometabolism in the specific brain areas altered 
by each of these two neurodegenerative disorders but rather to a more general disconnection 
process affecting several cerebral areas. Performance on the Stroop task is associated with a large 
network that is widely distributed throughout the cortex. This network involves the anterior 
cingulate gyrus, right orbitofrontal regions (Bench et al., 1993; Larrue et al., 1994; Pardo et al., 
1990), but also the left inferior frontal regions (Bush et al., 1998; George et al., 1994; Taylor et 
al., 1997), as well as temporal and parietal areas (Bush et al., 1998; Taylor et al., 1997). A 
disconnection process would lead to a less efficient transfer of information between the various 
cerebral areas involved in the Stroop task. In agreement with this hypothesis, many data lead one 
to consider AD as a disconnection syndrome (e.g., Collette et al., 2002c; for reviews, see 
Delbeuck et al., 2003; Morris, 1994). Although the hypothesis that there is a disconnection 
syndrome in FTD has not yet been formally tested, different clusters of metabolic covariance 
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have recently been highlighted in this disease, and a functional disconnection between those 
clusters is likely to subserve certain clinical symptoms in the disease (Salmon et al., 2006). In that 
context, the similar inhibitory impairment on the Stroop task in the two groups of patients could 
be related to a less efficient transfer of information within the network of areas involved in the 
Stroop task, rather than to a specific impairment of cerebral areas known to be hypometabolic 
from the first stages of AD and FTD. 
As indicated previously, behavioural disinhibition and impulsivity (referring to the 
production of socially inappropriate comments and/or actions) are prime characteristics of FTD 
(Cummings, 1993; Starkstein, 1997). However, this behavioural disinhibition was not 
accompanied in the present study by more severe cognitive inhibitory deficits in comparison to 
AD patients. These data suggest that social/behavioural inhibition may be relatively independent 
of cognitive inhibition. However, further studies will be necessary to determine the pattern of 
relationships between these two kinds of inhibitory processes in FTD. 
Finally, it has recently been stated that inhibitory measures might constitute an efficient 
way of differentiating between AD and FTD (Slachevsky et al., 2004; Dubois et al, 2000). 
However, our results indicate that none of the inhibitory measures investigated in this study can 
be used to discriminate between these two patient groups, and further studies will be necessary to 
evaluate the discriminatory power (i.e., the sensitivity and sensibility) of various inhibitory scores 
in the differential diagnosis of AD and FTD. It can be suggested that inhibitory tasks more related 
to social situations would be better adapted to discriminating between these populations than 
inhibitory tasks that explore very specific cognitive processes. 
In conclusion, the data obtained in the present study indicate that patients with AD and the 
frontal variant of FTD do not present a general decline in inhibitory functioning. Moreover, these 
two groups of patients present a similar impairment on the Stroop task, which may be related to 
the presence of a (partial) disconnection within the network of cerebral areas recruited during 
performance on the Stroop task. The existence of a specificity in the inhibitory dysfunction 
occurring in these two neurodegenerative diseases should nevertheless be replicated  in a large 
scale study using a wide range of tasks, build up to specifically assess different inhibitory 
processes. Indeed, our results concern only the inhibition of a dominant response in the verbal 
and motor domains, and other theoretical frameworks were proposed in the literature  
distinguishing between more specific inhibitory processes (e.g. Friedman & Miyake, 2004; Nigg, 
2000). Ideally, each process should be assessed by several experimental tasks to increase the 
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